Jon Cuthbert

CRCL climbed almost 16% on Monday after Circle reported stronger earnings and disclosed a $222 million ARC token presale tied to its blockchain infrastructure expansion plans.

Bioxyne (ASX:BXN) announced a major $50 million exclusive supply agreement with German pharmaceutical giant ADREXpharma.

Solana rallied 15% over the past week to trade near $97 as spot Solana ETFs attracted their strongest weekly inflows since February and derivatives positioning surged across crypto markets.

QXO (NYSE:QXO) reported first-quarter 2026 financial results that reflected broader cooling in the building products industry, alongside the impact of aggressive investments in the company’s buy-and-build strategy.

Cardinal Infrastructure Group (NASDAQ:CDNL) reported a 105% surge in first-quarter revenue, prompting the company to raise its full-year financial outlook as infrastructure demand across the Southeastern U.S. continues to outpace expectations.

SFL Corp. (NYSE:SFL) hiked its quarterly cash dividend to $0.22 per share, extending one of the longest payout streaks in the maritime industry as strong offshore demand and new financing activity bolstered its first-quarter results.

Coincheck Group (NASDAQ:CNCK) reported a net loss for its fiscal fourth quarter, as a downturn in cryptocurrency prices and a sharp pullback in retail trading activity offset gains in its institutional business.

Arvinas (NASDAQ:ARVN) reported that the U.S. Food and Drug Administration has approved VEPPANU (vepdegestrant) for the treatment of patients with ESR1-mutated ER+/HER2- advanced breast cancer.

Keenova Therapeutics (NYSE:MNK) posted first-quarter 2026 net sales from continuing operations of $468 million.

Organigram Global (NASDAQ:OGI) posted net revenue of $59.8 million for the quarter ended March 31, 2026, a 9% decrease from the same period last year.